Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission |
Non-radiographic Axial Spondyloarthritis | Phase4 |
Belgium Brazil Colombia Czechia France Germany Hungary Israel Italy Malaysia Mexico Netherlands Philippines Poland Romania Thailand Turkey Vietnam View All
|
NCT05622708 |
|
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy |
IgA Nephropathy, Immunoglobulin A Nephropathy | Phase2 |
Australia Brazil Korea, Republic of Malaysia Spain United States View All
|
NCT05834738 |
|
The Belgian REAL (BE.REAL) Registry |
Atherosclerotic Cardiovascular Disease | Belgium | NCT05726838 | |
|
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura® |
Asthma | Korea, Republic of | NCT05217810 | |
|
Dabrafenib and/or Trametinib Rollover Study |
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma | Phase4 |
Hungary Spain United States |
NCT03340506 |
|
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. |
C3G | Phase3 |
Brazil Canada France Germany Greece India Israel Italy Japan Netherlands Spain Switzerland Turkey United Kingdom United States View All
|
NCT04817618 |
|
Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) |
Primary Immune Thrombocytopenia (ITP) | Phase3 |
Argentina Australia Austria Belgium Bulgaria China Czechia France Germany Hong Kong Hungary India Italy Japan Malaysia Mexico Norway Romania Singapore Spain Thailand Turkey United Kingdom United States Vietnam View All
|
NCT05653349 |
|
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) |
Systemic Lupus Erythematosus | Phase3 |
Argentina Australia Chile Colombia France Germany India Italy Korea, Republic of Malaysia Mexico Romania Taiwan United Kingdom United States View All
|
NCT05624749 |
|
Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity |
Retinopathy of Prematurity | Korea, Republic of | NCT05304949 | |
|
A Prospective NIS to Evaluate the Clinical Outcomes of Risarg® (Ribociclib) Combined With Endocrine Therapy or Chemotherapy in Patients With HR+HER2 - aBC in Routine Clinical Practice in the Russia |
HR+HER2- Advanced Breast Cancer | Russian Federation | NCT06148506 |